Jaws Mustang Acquisition Corp: A Status Update

This guide explains how Jaws Mustang Acquisition Corp (Jaws) performed over the past year. I have translated complex filings into plain English to help you decide if this company fits your investment goals.

1. What does this company do?

Jaws is a "blank check" company, or a Special Purpose Acquisition Company (SPAC). It does not make products or provide services. Instead, it raises money through an IPO to buy a private company and take it public. Barry Sternlicht, CEO of Starwood Capital Group, founded Jaws. In February 2021, the company raised $900 million by selling 90 million shares at $10.00 each.

2. What happened this year?

It has been a difficult year. In early 2024, Jaws announced a merger with a hotel portfolio. By November 2024, they canceled the deal because the main hotel asset was sold to someone else.

Because Jaws missed its deadline to complete a merger, the NYSE American stock exchange delisted the company on November 25, 2024. The stock moved from the "JWSM" ticker to the OTC Pink Sheets under "JWSMQ." This move often leads to lower trading volume, wider price gaps between buyers and sellers, and less regulatory oversight.

3. Financial health: The "Going Concern" warning

Management has officially stated there is "substantial doubt" about the company’s ability to stay in business. In its latest report, the company lost about $2.1 million, mostly from administrative and legal fees. It has no revenue. To stay afloat, the company borrows money from its sponsor, Jaws Mustang Acquisition LLC. These loans now total over $1.5 million. These must be repaid or turned into shares, which would issue more shares and reduce your ownership percentage.

4. Key risks for you

• The "Clock" Risk: Jaws must liquidate if it does not complete a merger by its deadline. After the failed hotel deal, the company is racing to find a new target and gain shareholder approval before time runs out.
• The "Deal" Risk: Because of the delisting and financial warning, Jaws has little bargaining power. A target company might demand better terms, knowing Jaws is desperate to avoid closing down.
• Trading Hurdles: Being delisted makes the stock harder to trade. Many institutional investors and brokerages avoid OTC stocks. This often leads to higher price swings and difficulty buying or selling at your target price.
• Limited Protections: You have the right to redeem your shares for your portion of the cash held in the trust if a merger is proposed. However, if the company liquidates, the costs of closing the business will be taken from that cash. You may receive less than the original $10.00 per share.

5. The Bottom Line

Jaws is searching for a second chance after its primary deal failed. It is in a high-risk phase with no revenue and a ticking clock. Investing here is a bet on management’s ability to find a new company to buy before time expires. Given the delisting and financial warnings, the current stock price likely reflects a discount to the cash held in the trust. It is a speculative play on management’s ability to save the company.

Investor Checklist:

• Check your brokerage: Ensure your platform allows trading of OTC Pink Sheet stocks (ticker: JWSMQ).
• Monitor the trust value: Keep an eye on the company's filings for the current "redemption value" per share, which represents the cash backing your investment.
• Assess your risk tolerance: This is a distressed asset; only consider this if you are comfortable with the possibility of the company liquidating and returning less than your initial investment.